Cryptococcus neoformans serotype A is responsible for the majority of cryptococcal infections in AIDS patients. In France, approximately 17% of the patients are infected with serotype D, regardless of their human immunodeficiency virus status. In a retrospective study of 273 patients, we found that serotype D was unevenly distributed in France. We wondered if this was related to the yeast's genetic background. We used karyotyping and DNA fingerprints generated by UT-4p to analyze 40 serotype D clinical isolates. We found an extensive polymorphism, with only two conserved karyotypes from drug-addicted patients living in the same area. Although highly variable, the DNA fingerprints were classified into 10 groups. Four pairs of isolates were identical; three of these pairs were from patients living in the same area, but there was no other correlation with the geographical area. The two isolates with identical karyotypes belonged to the same fingerprint group. Five of the six isolates that made up fingerprint group I were recovered from drug-addicted patients (P < 0.002; chi-square), and all five isolates found in fingerprint group III were from male homosexual patients (P < 0.02). Finally, five of the seven isolates from patients with cryptococcal pneumonia were classified as fingerprint group V (P < 0.04). These results suggest that there are possible relationships between characteristics of the isolates and body localization or even risk factors. Results of the present study warrant other studies on isolates of all serotypes and on isolates from clinical and environmental sources.
mans var. gattii is still able to cause infection in non-AIDS patients. The disappearance of infections caused by serotypes B and C when the immune defect is related to the human immunodeficiency virus (HIV) remains unexplained.
If immunological studies were essential for the first description of the epidemiology, they cannot help in the analysis of strain variability. More discriminatory techniques are needed. Molecular 20. therefore been recently applied as epidemiological tools (5, 14, 15, 18-20, 25, 31) . These techniques have been described mostly with reference strains (or sometimes strains from culture collections) of the four serotypes or with clinical and environmental isolates collected in the United States and therefore mostly with strains of the A or B serotype. All studies dealing with the epidemiology of cryptococcal disease were issued from countries where strains of serotype D are present in low numbers or are even absent. Before the AIDS epidemic serotype D was described to be responsible for fewer than 5% of the infections in the United States, whereas it was a more frequent cause of infection in Europe, especially in Denmark and Italy (12) . Therefore, very little is known about the virulence of serotype D in AIDS patients and the genetic polymorphism of this serotype compared with that of serotype A.
Through the national survey on cryptococcosis initiated in France in 1985 , we were able to analyze 273 cases of cryptococcosis diagnosed between January 1990 and December 1992 and for which we had the corresponding infecting isolates. Of these, 17% were serotype D. We thus showed that serotype D is able to infect patients with AIDS since more than 80% of the patients with cryptococcosis were HIV infected (10 1991  1992  1992  1991  1992  1992  1992  1992  1992  1990  1992  1992  1991  1992  1992  1992  1990  1990  1991  1991  1991  1991  1991  1991  1992  1993  1991  1990  1990  1991  1991  1991  1991  1992  1992  1992  1991  1991  1991  1991  1992  1992  1992  1992  1993 strains (19, 26 Fig. 1 (Brittany, Paris, the suburbs of Paris, called Ile-de-France, eastern France, the Alps, Southeastern France, Southwestern France, and the center).
Serotyping of isolates. Identification of the clinical isolates as C. neoformans was always done by the laboratory where the yeast was first isolated and was usually done on Sabouraud dextrose agar. C. neofornans was identified by urease production in substrate urea-indole at 37°C, positive India ink preparation, and sugar assimilations with commercially available strips (API 20AUX or ID32C; bioMerieux, Marcy-l'Etoile, France). When required, the identification was checked at the National Reference Center for Mycosis. Serotyping was performed by a previously described method (9), combining diagnostic media and immunofluorescence assay with the monoclonal antibody El (11).
CHEF electrophoresis. Agarose blocks containing C. neoformans chromosomes from selected isolates were prepared by a procedure described before (13) . Saccharomyces cerevisiae chromosomes (Bio-Rad, Richmond, Calif.) were used as molecular size standards. Electrophoresis in 0.7% agarose was carried out on the contour-clamped homogeneous electric field (CHEF) DRII gel electrophoresis system (Bio-Rad) at 100 V with a dually ramped switch time of 100 to 200 s for 16 h and 200 to 300 s for 32 h. The buffer temperature was kept constant at 12°C throughout the run.
Southern blot analysis. DNAs were extracted from selected C. neoformans isolates as described before (30 impossible to obtain more information about potential common environmental sources of infection for the two patients, like friendship, sharing of syringes, or visiting the same places, because both patients died shortly after they were diagnosed with cryptococcosis. For another patient, the isolate that was recovered after 5 months of antifungal therapy with fluconazole was found to be identical to the patient's initial isolate (Fig. 3) .
Fingerprinting of serotype D isolates with UT-4p. Comparison of the patterns was made easier by the fact that electrophoresis of the 31 digested DNAs was performed on the same day by using the same power supply. Likewise, transfer and hybridization were performed during one unique experiment. The migrations of the bands in the standard ladder were therefore similar in all gels. By using the probe, the reproducibility of the patterns had previously been checked with various isolates, including those from a culture collection, clinical isolates cultured from different body sites of the same patient, and isolates obtained after experimental infection of mice (30) . The reproducibility was checked during this experiment with reference strains of the four serotypes. The patterns of the serotype D clinical isolates were then checked only once.
Hybridization with the radiolabelled plasmid UT-4p generated highly variable restriction fragment patterns (Fig. 4) Table 2 ). This classification was made blindly and ended with 10 groups (groups I to X). Five groups (II, IV, VII, VIII, and X) contained only one isolate each. The other five groups included between 2 and 10 different isolates. Variability within a group was limited to small variations in the size of the higher-molecular-mass bands, especially in group I, which had two strains with identical patterns (isolates D2 and D17) and little variation among the remaining members of this group, including isolate D13. We also found isolates with identical patterns in group V (isolates D21 and D27 and isolates D10 and D22), and group IX was composed of two identical isolates (isolates D3 and D5).
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Except for isolates D21 and D27, which were cultured from patients who lived in southwestern France and Ile-de-France, respectively (and for whom no information about possible travel to the other patient's region was available), the pairs of isolates with identical patterns were found for patients living in the same geographical area. However, there was no correlation between the pattern group and the geographical area of diagnosis. The number of patients with a risk factor for cryptococcosis independent of HIV infection was too small to analyze any possible connection, as was the number of nonCaucasian patients.
We then looked at the possible relationship between the type of cryptococcal isolate infecting the patient and the risk factor for HIV infection or the body site where the isolate was found. Group I comprised six isolates, with five isolates recovered from drug-addicted patients (P < 0.002; chi-square), whereas group III contained only five isolates, all from male homosexual patients (P < 0.02). There was no apparent link between a pattern group and localization of the isolate in cerebrospinal fluid, urine, or skin. On the other hand, a small number of DNA fingerprint groups contained isolates recovered from blood or lungs. Five of the seven isolates cultured from patients with cryptococcal pneumonia, whether or not they were associated with meningitis or with other body locations, were in group V (P < 0.04). Interestingly, among these five isolates, isolates D10 and D22 and isolates D21 and D27 had identical DNA fingerprints.
DISCUSSION
Strain variations among C. neoformans serotype A isolates have been demonstrated by using biochemical (4, 28) , immunological (9, 23, 24, 27) , and molecular typing (18, 19, 31) b Number of isolates that were cultured from the following sites: cerebrospinal fluid (C), blood (B), urine (U), lung (L), skin (S), and lymph node (LN).
See footnote c to (16) . Among the 40 isolates analyzed, two had one band at the place of the minichromosome previously described by Varma and Kwon-Chung (29) . As expected, we did not find a specific pattern associated with the ethnic origin of the patients, the geographical area of diagnosis, or the clinical site of infection, a finding already noted for serotype A (19) .
The karyotyping technique allows for the rapid screening of selected isolates. It is reproducible and easy to perform. However, the results were disappointing since the patterns were so dissimilar that it prevented any kind of grouping when looking at a small number of isolates from different patients. We found that only 2 of the 40 serotype D clinical isolates had a similar karyotype, and Perfect et al. (19) described 5 isolates with two conserved karyotypes of the 46 serotype A isolates that they studied. While these isolates were from individuals with no common background, our isolates were cultured from two drug-addicted patients who lived in the same geographical area. This may suggest that karyotyping could be useful for large epidemiological studies involving hundreds of isolates and might then detect similarities more often. Nevertheless, it is a convenient technique for studying isolates recovered from the same patient for a prolonged period of time or for comparing the isolates recovered during a relapse(s) and the initial isolate (26) .
When isolates have a conserved karyotype or when one works with a limited number of them, other degrees of resolution are necessary to look for relatedness. The DNA fingerprints generated with UT-4p were, in our hands, helpful in allowing us to validate our serotyping method using the monoclonal antibody El and to distinguish between isolates of the D serotype. In the first report on UT-4p, serotype D exhibited the most variable DNA fingerprint of the four serotypes examined. In the present study, only four pairs of isolates had identical patterns. We arbitrarily and blindly designed groups on the basis of similarities in the number of bands larger than 2.5 kb and ended up with 10 groups each containing 1 to 10 isolates. The purpose of this classification was to look for a correlation between a group and characteristics of the patient or the isolate. We found several isolates that could fit in the same group, with small variations in the sizes of the bands. We did not collect enough isolates from non-AIDS or non-Caucasian patients to make conclusions on these points. Other studies have reported that there are no differences in the C. neoformans isolates that infect AIDS and non-AIDS patients (7, 15, 31) . The geographical area where the patient was diagnosed bore no relationship to any group except for isolates with identical patterns, which were obtained from patients coming from the same area in three of the four cases. The two isolates with a conserved karyotype were found in the same fingerprint group, group I. One of these isolates (isolate D2) had a DNA fingerprint identical to that of another isolate (isolate D17). All three isolates were recovered from drug-addicted patients living in the same area. However, we do not have enough information to confirm that this cluster of isolates with apparently the same DNA sequences came from a common exposure. The heterogeneity of isolates coming from the same area was also recently reported for serotype A isolates by Varma 
